Research programme: neuronal nitric oxide synthase inhibitors - Guilford
Alternative Names: Neuronal nitric oxide synthase inhibitors research programme - GuilfordLatest Information Update: 25 Sep 2021
At a glance
- Originator MGI GP
- Class
- Mechanism of Action Nitric oxide synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 22 Dec 2000 Discontinued-Preclinical for Neurological disorders (Prevention) in USA (Unknown route)
- 26 Mar 1998 Preclinical development for Neurological disorders (Prevention) in USA (Unknown route)